Full Text View
Tabular View
No Study Results Posted
Related Studies
Sitosterolemia Extension Study (0653-003)(COMPLETED)
This study has been completed.
Study NCT00092807   Information provided by Merck

First Received on September 23, 2004.   Last Updated on May 24, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lipid Metabolism, Inborn Errors
Heart Disease
Additional conditions recognized in this trial
Heart Diseases
Hypercholesterolemia
Intestinal Diseases
Metabolism, Inborn Errors
More general conditions related to this trial
Cardiovascular Diseases
Digestive System Diseases
Dyslipidemias
Gastrointestinal Diseases
Genetic Diseases, Inborn
Hyperlipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
MK0653, ezetimibe
Comparator: placebo
Additional drug interventions recognized in this trial
Ezetimibe
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services